Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors

Molecular Therapy

Volumn 3, Issue 5, 2001, Pages 708-722

  Schnell, Michael A ^a   Zhang, Yi ^a   Tazelaar, John ^a   Gao, Guang Ping ^a   Yu, Q C ^a   Qian, Ruth ^a   Chen, Shu Jen ^a   Varnavski, Andrei N ^a   LeClair, Cynthia ^a   Raper, Steven E ^a   Wilson, James M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BETA GALACTOSIDASE; CAPSID PROTEIN; FLUORESCENT DYE; INTERLEUKIN 6; PSORALEN; VIRUS VECTOR;

ADENOVIRUS; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; BONE MARROW CULTURE; CELL ACTIVATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DISSEMINATED INTRAVASCULAR CLOTTING; ERYTHROID CELL; GENE EXPRESSION; GENE INACTIVATION; GENE TARGETING; IMMUNITY; INFUSION; KUPFFER CELL; LIVER; LYMPHOCYTOPENIA; MACROPHAGE; MALE; MORBIDITY; NONHUMAN; PETECHIA; PRIMATE; PROMYELOCYTE; RHESUS MONKEY; SPLEEN; THROMBOCYTOPENIA; ULTRAVIOLET IRRADIATION; VIRUS CAPSID;

ADENOVIRIDAE; ANIMALIA; MACACA MULATTA; MIRIDAE; PRIMATES;

EID: 17844393413     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2001.0330     Document Type: Article

References (52)

1. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector
2. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
3. Humoral immune response to the capsid components of recombinant adenoviruses: Routes of immunization modulate virus-induced lg subclass shifts
4. Recombinant IL-12 prevents formation of blocking lgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung
5. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses
6. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses
7. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy
8. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice
9. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors
10. Adenovirus-mediated transfer of human factor IX gene in immunodeficient and normal mice: Evidence for prolonged stability and activity of the transgene in liver
11. Immune responses to reporter proteins and high viral dose limit duration of expression with adeno-viral vectors: Comparison of E2a wild type and E2a deleted vectors
12. Assessment of recombinant adenoviral vectors for hepatic gene therapy
13. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis
14. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA
15. Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates
16. Liver-directed gene transfer in non-human primates
17. Toxicological comparison of E2a-deleted and first-generation adenoviral vectors expressing alpha1-antitrypsin after systemic delivery
18. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers
19. Biology of adenoviral vectors deleted of E1 and E4 for liver-directed gene therapy
20. Persistent transgene expression in mouse liver following in vivo gene transfer with a ΔE1/ΔE4 adenovirus vector
21. Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses
22. Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products
23. Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor
24. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons
25. High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity
26. A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency
27. Lethal systemic inflammatory response syndrome in a patient with partial ornithine transcarbamylase deficiency following intravascular administration of recombinant adenoviral vector. In preparation
28. Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver
29. Recombinant adenovirus induces maturation of dendritic cells via an NF-κB-dependent pathway
30. Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages
31. Immunophenotypic characterization of simian immunodeficiency virus-infected dendritic cells in cervix, vagina, and draining lymph nodes of rhesus monkeys
32. Dendritic cell subtypes in mouse lymphoid organs: Cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen and lymph nodes
33. The effect of simian immunodeficiency virus infection in vitro and in vivo on the cytokine production of isolated microglia and peripheral macrophages from rhesus monkey
34. Dendrite cell-T cell mixtures, isolated from the skin and mucosae of macaques, support the replication of SIV
35. Characterization of nonhuman primate epidermal and dermal dendritic cells with monoclonal antibodies. A study of Langerhans cells and indeterminate cells in the rhesus monkey
36. The distinct surface of human blood dendritic cells, as observed after an improved isolation method
37. Immunobiology of dendritic cells
38. Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients
39. Inhibition of immature erythroid progenitor cell proliferation by macrophage inflammatory protein-1alpha by interacting mainly with a C-C chemokine receptor, CCR1
40. Gene transfer into the liver of nonhuman primates with E1-deleted recombinant adenoviral vectors: Safety of readministration
41. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle
42. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: Comparisons between immunocompetent and immunodeficient inbred strains
43. The impact of development stage, route of administration, and the immune system on adenovirus-mediated gene transfer
44. Adenovirus-mediated gene transfer: Influence of transgene, mouse strain and type of immune response on persistence of transgene expression
45. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues
46. Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: Implications for gene therapy
47. Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4-deleted recombinant adenoviruses
48. Postinjury multiple organ failure: A bimodal phenomenon
49. Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells
50. In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A*0201-restricted CD8+ T cells in patients with melanoma